Active formulation for use in feed products
Abstract
Invention pertains to a free-flowing particulate powder including 2-90 wt. % of an active compound on a carrier, wherein the carrier has a D(v,0.1) of at least 100 microns, with the active compound being selected from lactylate in accordance with formula (1), Formula (1): R2-COO—[—CH(CH3)-COO]n-R1 or a Na, K, Ca, Mg, Fe(II), Zn, NH4, or Cu(II) salt thereof, a glycolylate of formula (2), Formula (2): R2-COO—[—CH2-COO]n-R1 or a Na, K, Ca, Mg, Fe(II), Zn, NH4, or Cu(II) salt thereof a lactate ester of formula (3), Formula (3): HO—CH(CH3)-COO—R2 and/or a glycolic acid ester of formula (4), Formula (4): HO—CH2-COO—R2 wherein in the above formulae R1 is selected from H, n stands for an integer with a value of 1-10, and R2 stands for a C1-C35 alkyl or alkenyl chain which may be branched or unbranched. The powder allows easy provision of the active compound to feed compositions.
Claims
exact text as granted — not AI-modified1 . A free-flowing particulate powder comprising 10-90 wt. % of an active compound on a porous carrier, wherein the carrier has a D(v,0.1) of at least 100 microns, with the active compound being selected from lauroyl lactylate, myristoyl lactylate, their sodium salts, and mixtures thereof.
2 . The powder according to claim 1 , wherein the powder has a Hausner ratio of at most 1.25.
3 . The powder according to claim 1 , wherein the powder comprises at least 20 wt. % of the active compound.
4 . The powder according to claim 1 , wherein the carrier has a surface area, as determined through BET, of at least 10 m 2 /g.
5 . The powder according to claim 1 , wherein the carrier has a pore volume of at least 0.1 ml/g.
6 . The powder according to claim 1 , wherein the carrier has a bulk density of at least 0.1 g/ml.
7 . The powder according to claim 1 , wherein the carrier is a porous inorganic oxide.
8 . The powder according to claim 1 , wherein the carrier is an organic porous material.
9 . The powder according to claim 1 , wherein the active compound is a mixture comprising lauroyl lactylate and myristolyl lactylate, or the sodium salts of these compounds.
10 . The powder according to claim 9 , wherein the mixture comprises 5-95 wt. % lauroyl lactylate, and 5-95 wt. % myristoyl lactylate, or the sodium salts of these compounds.
11 . The powder according to claim 9 , wherein the mixture comprises 25-75 wt. % lauroyl lactylate, and 75-25 wt. % myristoyl lactylate, or the sodium salts of these compounds.
12 . A method for manufacturing a powder according to claim 1 , comprising contacting the active compound in the liquid form with the carrier.
13 . The method for manufacturing a powder according to claim 12 , wherein the contacting the active compound in the liquid form with the carrier is carried out at a pressure below 800 mbar.
14 . An animal nutrition composition comprising the powder according to claim 1 and at least one further nutritious component.
15 . An animal nutrition composition comprising the powder according to claim 1 .
16 . A method for preventing or treating intestinal infections caused by gram-positive bacteria in animals, and/or increasing the growth of the animal, comprising feeding the animal an effective amount of the powder of claim 1 .
17 . The powder according to claim 1 , wherein the carrier has a D(v,0.5) of between 300 and 800 microns.Join the waitlist — get patent alerts
Track US2018064675A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.